Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram

Joint · Humacyte, Inc. · Humacyte, Inc. - Common Stock
Purchase
Disclosed range starting at $15K
Disclosed 867 days after execution (STOCK Act deadline: 45)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Kuznik Paul BrianDirector | Grant or award | A | — 125.0K sh | Oct 7, 2026 traded Oct 6, 2026 | |
| 46 | Tommy TubervilleRJoint | Sale (Partial) | SELL | $15K – $50K | Aug 5, 2026 traded May 3, 2024 | |
| 39 | Tommy TubervilleRJoint | Purchase | BUY | $1,001 – $15K | Aug 5, 2026 traded Mar 21, 2024 | |
| 42 | Tommy TubervilleRJoint | Sale (Full) | SELL | $1,001 – $15K | Aug 5, 2026 traded May 3, 2024 | |
| 39 | Tommy TubervilleRJoint | Purchase | BUY | $1,001 – $15K | Aug 5, 2026 traded Mar 21, 2024 | |
| 14 | Sander Dale A.CFO and Chief Corp. Dev. Off | Open-market sale · 10b5-1 plan | SELL | $41K 45.9K sh | May 20, 2026 traded May 18, 2026 | |
| 14 | Parikh Shamik JChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $41K 45.9K sh | May 20, 2026 traded May 18, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.
= $32,501
Tommy Tuberville reported a purchase of Humacyte, Inc. - Common Stock (owner: joint). Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.